These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 34142308)

  • 1. Lumbar cerebrospinal fluid-to-brain extracellular fluid surrogacy is context-specific: insights from LeiCNS-PK3.0 simulations.
    Saleh MAA; Loo CF; Elassaiss-Schaap J; De Lange ECM
    J Pharmacokinet Pharmacodyn; 2021 Oct; 48(5):725-741. PubMed ID: 34142308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisiting Cerebrospinal Fluid Flow Direction and Rate in Physiologically Based Pharmacokinetic Model.
    Hirasawa M; de Lange ECM
    Pharmaceutics; 2022 Aug; 14(9):. PubMed ID: 36145511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using the LeiCNS-PK3.0 Physiologically-Based Pharmacokinetic Model to Predict Brain Extracellular Fluid Pharmacokinetics in Mice.
    Saleh MAA; Gülave B; Campagne O; Stewart CF; Elassaiss-Schaap J; de Lange ECM
    Pharm Res; 2023 Nov; 40(11):2555-2566. PubMed ID: 37442882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Extension of the LeiCNS-PK3.0 Model in Combination with the "Handshake" Approach to Understand Brain Tumor Pathophysiology.
    Hirasawa M; Saleh MAA; de Lange ECM
    Pharm Res; 2022 Jul; 39(7):1343-1361. PubMed ID: 35258766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug Distribution in Brain and Cerebrospinal Fluids in Relation to IC
    Saleh MAA; Bloemberg JS; Elassaiss-Schaap J; de Lange ECM
    Pharm Res; 2022 Jul; 39(7):1303-1319. PubMed ID: 35606598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of CNS Diseases on Drug Delivery to Brain Extracellular and Intracellular Target Sites in Human: A "WHAT-IF" Simulation Study.
    Saleh MAA; de Lange ECM
    Pharmaceutics; 2021 Jan; 13(1):. PubMed ID: 33451111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central nervous system pharmacokinetics of the Mdr1 P-glycoprotein substrate CP-615,003: intersite differences and implications for human receptor occupancy projections from cerebrospinal fluid exposures.
    Venkatakrishnan K; Tseng E; Nelson FR; Rollema H; French JL; Kaplan IV; Horner WE; Gibbs MA
    Drug Metab Dispos; 2007 Aug; 35(8):1341-9. PubMed ID: 17470526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of utility of cerebrospinal fluid drug concentration as a surrogate for interstitial fluid concentration using microdialysis coupled with cisternal cerebrospinal fluid sampling in wild-type and Mdr1a(-/-) rats.
    Nagaya Y; Nozaki Y; Takenaka O; Watari R; Kusano K; Yoshimura T; Kusuhara H
    Drug Metab Pharmacokinet; 2016 Feb; 31(1):57-66. PubMed ID: 26830080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Minimal Physiologically Based Pharmacokinetic Model to Characterize CNS Distribution of Metronidazole in Neuro Care ICU Patients.
    Chauzy A; Bouchène S; Aranzana-Climent V; Clarhaut J; Adier C; Grégoire N; Couet W; Dahyot-Fizelier C; Marchand S
    Antibiotics (Basel); 2022 Sep; 11(10):. PubMed ID: 36289950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamics.
    Shen DD; Artru AA; Adkison KK
    Adv Drug Deliv Rev; 2004 Oct; 56(12):1825-57. PubMed ID: 15381336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous evaluation of single-dose moxifloxacin concentrations in brain extracellular fluid, cerebrospinal fluid, and plasma: a novel porcine model.
    Mariager T; Terkelsen JH; Bue M; Öbrink-Hansen K; Nau R; Bjarkam CR; Nielsen H; Bodilsen J
    J Antimicrob Chemother; 2024 Jun; 79(6):1313-1319. PubMed ID: 38573940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of CSF in translational neuroscience.
    de Lange EC
    J Pharmacokinet Pharmacodyn; 2013 Jun; 40(3):315-26. PubMed ID: 23400635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PBPK LeiCNS-PK3.0 framework predicts Nirmatrelvir (but not Remdesivir or Molnupiravir) to achieve effective concentrations against SARS-CoV-2 in human brain cells.
    Saleh MAA; Hirasawa M; Sun M; Gülave B; Elassaiss-Schaap J; de Lange ECM
    Eur J Pharm Sci; 2023 Feb; 181():106345. PubMed ID: 36462547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topotecan central nervous system penetration is altered by a tyrosine kinase inhibitor.
    Zhuang Y; Fraga CH; Hubbard KE; Hagedorn N; Panetta JC; Waters CM; Stewart CF
    Cancer Res; 2006 Dec; 66(23):11305-13. PubMed ID: 17145877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular fluid concentrations of cisplatin, carboplatin, and oxaliplatin in brain, muscle, and blood measured using microdialysis in nonhuman primates.
    Jacobs S; McCully CL; Murphy RF; Bacher J; Balis FM; Fox E
    Cancer Chemother Pharmacol; 2010 Apr; 65(5):817-24. PubMed ID: 19662415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of human CNS pharmacokinetics using a physiologically-based pharmacokinetic modeling approach.
    Yamamoto Y; Välitalo PA; Wong YC; Huntjens DR; Proost JH; Vermeulen A; Krauwinkel W; Beukers MW; Kokki H; Kokki M; Danhof M; van Hasselt JGC; de Lange ECM
    Eur J Pharm Sci; 2018 Jan; 112():168-179. PubMed ID: 29133240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiologically based pharmacokinetic modeling to investigate regional brain distribution kinetics in rats.
    Westerhout J; Ploeger B; Smeets J; Danhof M; de Lange EC
    AAPS J; 2012 Sep; 14(3):543-53. PubMed ID: 22588644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring K
    Zhang M; Vuist IM; Rottschäfer V; de Lange EC
    Eur J Pharm Sci; 2024 Dec; 203():106883. PubMed ID: 39181172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of P-Glycoprotein-Mediated Active Efflux on Drug Distribution into Lumbar Cerebrospinal Fluid in Nonhuman Primates.
    Nagaya Y; Katayama K; Kusuhara H; Nozaki Y
    Drug Metab Dispos; 2020 Nov; 48(11):1183-1190. PubMed ID: 32862147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple drug transporters contribute to the brain transfer of levofloxacin.
    Cen Y; Shan Y; Zhao J; Xu X; Nie Z; Zhang J
    CNS Neurosci Ther; 2023 Jan; 29(1):445-457. PubMed ID: 36253925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.